MedPath
FDA Approval

itraconazole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 16, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Itraconazole(10 mg in 1 mL)

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Janssen Pharmaceutical Sciences Unlimited Company

Patriot Pharmaceuticals, LLC

985639841

Janssen Pharmaceutica, NV

Patriot Pharmaceuticals, LLC

370005019

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

itraconazole

Product Details

NDC Product Code
10147-0150
Application Number
NDA020657
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
November 16, 2023
ADRABETADEXInactive
Code: 8W6Q67R6NXClass: IACTQuantity: 400 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
CHERRYInactive
Code: BUC5I9595WClass: IACT
CARAMELInactive
Code: T9D99G2B1RClass: IACT
Code: 304NUG5GF4Class: ACTIBQuantity: 10 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath